The purpose of this study is to evaluate the safety and efficacy of an investigational anti-anxiety medication relative to placebo in patients with generalized anxiety disorder (GAD).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Masking
DOUBLE
Enrollment
880
Reduction of symptomatology associated with Generalized Anxiety Disorder as assessed by the change from baseline to end point in the total score of the HAM-A scale.
Assessment of proportion of responders and patients in remission according to HAM-A scores and CGI ratings by visit, assessment of the safety and tolerability in patients with GAD
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Pivotol Research Centers
Mesa, Arizona, United States
Pivotal Research Center
Peoria, Arizona, United States
Valley Clinical Research
El Centro, California, United States
Radiant Research Irvine
Irvine, California, United States
Pharmacology Research Institute
Los Alamitos, California, United States
Pharmacology Research Institute
Riverside, California, United States
Clinical Innovations, Inc.
Santa Ana, California, United States
Radiant Research
Denver, Colorado, United States
University of Connecticut Health Center
Farmington, Connecticut, United States
Miami Research Associates
Miami, Florida, United States
...and 44 more locations